Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A phase I investigator initiated inhalation safety trial of AB569 in healthy volunteers.

Next Previous
Trial Profile

A phase I investigator initiated inhalation safety trial of AB569 in healthy volunteers.

Status: Suspended
Phase of Trial: Phase I

Latest Information Update: 22 Jun 2018

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Nitrite (Primary)
  • Indications Burkholderia cepacia infections; Pseudomonal infections; Staphylococcal infections
  • Focus Adverse reactions; First in man

    • Most Recent Events

    • 19 Jun 2018 According to an Arch Biopartners media release, the company will seek regulatory guidance from the US FDA in the a pre-Investigational New Drug (pre-IND) meeting for AB-569. This trial will be on hold and will resume again after the IND application is opened and the FDA approves the phase I study.
    • 19 Jun 2018 Arch Biopartners media release, status changed from recruiting to suspended.
    • 27 Mar 2018 According to an Arch Biopartners media release, the first patients were recruited and enrolled in the trial in February 2018. Dr. Ralph Panos is the lead investigator of the trial.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top